Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Global Market Study on Meningococcal Vaccines: Awareness and Accessibility Instrumenting Inroads into Untapped Markets

Table of Content

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply Side Trends
    1.4. Analysis and Recommendations

2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations

3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Product Innovation 

4. Key Success Factors
    4.1. Pipeline Analysis
    4.2. Recent Product Launches 
    4.3. Promotional Strategies, by Manufacturers
    4.4. Regulatory Scenario

5. Global Meningococcal Vaccine Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
    5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
    5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
        5.2.1. Y-o-Y Growth Trend Analysis
        5.2.2. Absolute $ Opportunity Analysis

6. Market Background
    6.1. Macro-Economic Factors
        6.1.1. Global Healthcare Spending Outlook
        6.1.2. Global Pharmaceutical Outlook
        6.1.3. Regional Healthcare Market Outlook
    6.2. Forecast Factors – Relevance & Impact
    6.3. Value Chain
    6.4. Pipeline Analysis
    6.5. Market Dynamics
        6.5.1. Drivers
        6.5.2. Restraints
        6.5.3. Opportunity Analysis

7. Global Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type 
    7.1. Introduction / Key Findings
    7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 – 2018
    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 – 2029
        7.3.1. Meningococcal Polysaccharide Vaccine (MPSV4)
        7.3.2. Meningococcal Conjugate Vaccine (MCV4)
        7.3.3. Serogroup B Meningococcal Vaccine (MenB-FHpb/MenB-4C)
    7.4. Market Attractiveness Analysis By Product Type 

8. Global Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Age Group
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2014 – 2018
    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Age Group, 2019 – 2029
        8.3.1. Infants (0-24 months)
        8.3.2. Children
        8.3.3. Adolescents and Young Adults
        8.3.4. Adults
    8.4. Market Attractiveness Analysis By Age Group

9. Global Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 – 2018
    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029
        9.3.1. Institutional Sales
            9.3.1.1. Hospitals
            9.3.1.2. Community Clinics
            9.3.1.3. Public Health Agencies
        9.3.2. Retail Sales
            9.3.2.1. Retail Pharmacy
            9.3.2.2. Mail Order Pharmacy
    9.4. Market Attractiveness Analysis By Distribution Channel

10. Global Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Region
    10.1. Introduction
    10.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2014 – 2018
    10.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2019 – 2029
        10.3.1. North America
        10.3.2. Latin America
        10.3.3. Europe
        10.3.4. East Asia
        10.3.5. South Asia
        10.3.6. Oceania
        10.3.7. Middle East and Africa (MEA)
    10.4. Market Attractiveness Analysis By Region

11. North America Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029
    11.1. Introduction
    11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 – 2018
    11.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029
        11.3.1.  By Country
            11.3.1.1. U.S.
            11.3.1.2. Canada
        11.3.2. By Product Type
        11.3.3. By Age Group
        11.3.4. By Distribution Channel
    11.4. Market Attractiveness Analysis
    11.5. Market Trends
    11.6. Key Market Participants – Intensity Mapping
    11.7. Drivers and Restraints – Impact Analysis

12. Latin America Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029
    12.1. Introduction
    12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 – 2018
    12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029
        12.3.1.  By Country
            12.3.1.1. Brazil
            12.3.1.2. Mexico
            12.3.1.3. Rest of Latin America
        12.3.2. By Product Type
        12.3.3. By Age Group
        12.3.4. By Distribution Channel
    12.4. Market Attractiveness Analysis
    12.5. Market Trends
    12.6. Key Market Participants – Intensity Mapping
    12.7. Drivers and Restraints – Impact Analysis

13. Europe Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029
    13.1. Introduction
    13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 – 2018
    13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029
        13.3.1.  By Country
            13.3.1.1. Germany
            13.3.1.2. Italy
            13.3.1.3. France
            13.3.1.4. U.K.
            13.3.1.5. Spain
            13.3.1.6. BENELUX
            13.3.1.7. Russia
            13.3.1.8. Rest of Europe
        13.3.2. By Product Type
        13.3.3. By Age Group
        13.3.4. By Distribution Channel
    13.4. Market Attractiveness Analysis
    13.5. Market Trends
    13.6. Key Market Participants – Intensity Mapping
    13.7. Drivers and Restraints – Impact Analysis

14. South Asia Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029
    14.1. Introduction
    14.2. Pricing Analysis
    14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 – 2018
    14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029
        14.4.1.  By Country
            14.4.1.1. India
            14.4.1.2. Thailand
            14.4.1.3. Indonesia
            14.4.1.4. Malaysia
            14.4.1.5. Rest of South Asia
        14.4.2. By Product Type
        14.4.3. By Age Group
        14.4.4. By Distribution Channel
    14.5. Market Attractiveness Analysis
    14.6. Market Trends
    14.7. Key Market Participants – Intensity Mapping
    14.8. Drivers and Restraints – Impact Analysis

15. East Asia Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029
    15.1. Introduction
    15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 – 2018
    15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029
        15.3.1.  By Country
            15.3.1.1. China
            15.3.1.2. Japan
            15.3.1.3. South Korea
        15.3.2. By Product Type
        15.3.3. By Age Group
        15.3.4. By Distribution Channel
    15.4. Market Attractiveness Analysis
    15.5. Market Trends
    15.6. Key Market Participants – Intensity Mapping
    15.7. Drivers and Restraints – Impact Analysis

16. Oceania Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029
    16.1. Introduction
    16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 – 2018
    16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029
        16.3.1.  By Country
            16.3.1.1. Australia
            16.3.1.2. New Zealand
        16.3.2. By Product Type
        16.3.3. By Age Group
        16.3.4. By Distribution Channel
    16.4. Market Attractiveness Analysis
    16.5. Market Trends
    16.6. Key Market Participants – Intensity Mapping
    16.7. Drivers and Restraints – Impact Analysis

17. Middle East and Africa Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029
    17.1. Introduction
    17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 – 2018
    17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029
        17.3.1.  By Country
            17.3.1.1. GCC Countries
            17.3.1.2. Turkey
            17.3.1.3. Northern Africa
            17.3.1.4. South Africa
            17.3.1.5. Rest of Middle East and Africa
        17.3.2. By Product Type
        17.3.3. By Age Group
        17.3.4. By Distribution Channel
    17.4. Market Attractiveness Analysis
    17.5. Market Trends
    17.6. Key Market Participants – Intensity Mapping
    17.7. Drivers and Restraints – Impact Analysis

18. Emerging Countries Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029
    18.1. Introduction
        18.1.1. Market Value Proportion Analysis, By Key Countries
        18.1.2. Global Vs. Country Growth Comparison
    18.2. China Meningococcal Vaccine Market Analysis
        18.2.1. Introduction
        18.2.2. PEST Analysis
        18.2.3. Market Value Proportion Analysis by Market Taxonomy
        18.2.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
            18.2.4.1. By Product Type
            18.2.4.2. By Age Group
            18.2.4.3. By Distribution Channel
    18.3. India Meningococcal Vaccine Market Analysis
        18.3.1. Introduction
        18.3.2. PEST Analysis
        18.3.3. Market Value Proportion Analysis by Market Taxonomy
        18.3.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
            18.3.4.1. By Product Type
            18.3.4.2. By Age Group
            18.3.4.3. By Distribution Channel
    18.4. Brazil Meningococcal Vaccine Market Analysis
        18.4.1. Introduction
        18.4.2. PEST Analysis
        18.4.3. Market Value Proportion Analysis by Market Taxonomy
        18.4.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
            18.4.4.1. By Product Type
            18.4.4.2. By Age Group
            18.4.4.3. By Distribution Channel

19. Market Structure Analysis
    19.1. Market Analysis by Tier of Companies (Meningococcal Vaccine)
    19.2. Market Share Analysis of Top Players
    19.3. Brand Share Analysis
    19.4. Market Presence Analysis
        19.4.1. By Regional footprint of Players
        19.4.2. Product foot print by Players
        19.4.3. Channel Foot Print by Players

20. Competition Analysis
    20.1. Competition Dashboard
    20.2. Pricing Analysis by Competition
    20.3. Competition Benchmarking
    20.4. Competition Deep Dive 
        20.4.1. Sanofi Pasteur Inc.
            20.4.1.1. Overview
            20.4.1.2. Product Portfolio
            20.4.1.3. Profitability by Market Segments (Product/Channel/Region)
            20.4.1.4. Sales Footprint
            20.4.1.5. Strategy Overview
                20.4.1.5.1. Marketing Strategy
                20.4.1.5.2. Product Strategy
                20.4.1.5.3. Channel Strategy
        20.4.2. GlaxoSmithKline
            20.4.2.1. Overview
            20.4.2.2. Product Portfolio
            20.4.2.3. Profitability by Market Segments (Product/Channel/Region)
            20.4.2.4. Sales Footprint
            20.4.2.5. Strategy Overview
                20.4.2.5.1. Marketing Strategy
                20.4.2.5.2. Product Strategy
                20.4.2.5.3. Channel Strategy
        20.4.3. Wyeth Pharmaceuticals
            20.4.3.1. Overview
            20.4.3.2. Product Portfolio
            20.4.3.3. Profitability by Market Segments (Product/Channel/Region)
            20.4.3.4. Sales Footprint
            20.4.3.5. Strategy Overview
                20.4.3.5.1. Marketing Strategy
                20.4.3.5.2. Product Strategy
                20.4.3.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote